[ $^{188}Re$ ]-Labeled Radiopharmaceuticals

$^{188}Re$ 표지 방사성의약품

  • Jeong, Jae-Min (Department of Nuclear Medicine Seoul National University College of Medicine)
  • 정재민 (서울대학교 의과대학 핵의학교실)
  • Published : 2001.10.30

Abstract

The search for an ideal radioisotope for radiotherapy continues. As a generator-produced radioisotope emitting both beta and gamma rays with a short physical half-life of 16.9 hr, $^{188}Re$ is an excellent candidate for radiotherapy. Its applications Include the irradiation of coronary artery to prevent restenosis, treatment of rheumatoid arthritis, treatment of peritoneal effusion, palliation of metastatic bone pain, and treatment of liver cancer.

Keywords